Consumer Acceptance and Expectations of a Mobile Health Application to Photograph Skin Lesions for Early Detection of Melanoma

Koh, Uyen; Horsham, Caitlin; Soyer, H. Peter; Loescher, Lois J.; Gillespie, Nicole; Vagenas, Dimitrios; Janda, Monika

doi:10.1159/000493728

Cited by 39 publications

(28 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…12 In a more recent study, the authors have found 95% ( n =84/88) of consumers would consider sending photos of their skin lesions to a medical practitioner via an app. 16 Alternatively, another variant of direct-to-consumer services is patients sending images to a medical practitioner with whom they have a known doctor–patient relationship. This would be useful for monitoring a lesion over time, or could be used to select a suspicious lesion that the patient identifies for telediagnosis.…”

Section: Introductionmentioning

confidence: 99%

Evaluating healthcare practitioners’ views on store-and-forward teledermoscopy services for the diagnosis of skin cancer

et al. 2019

Self Cite

View full text Add to dashboard Cite

Objective The aim of the study is to evaluate healthcare practitioners’ views on and satisfaction with (i) digital image acquisition and storage and (ii) store-and-forward teledermoscopy services for the diagnosis of skin cancer in their clinical practice. Methods An online survey was conducted among 59 healthcare practitioners (GPs ( n =17), dermatologists ( n =22), dermatology registrars ( n =18), a dermatology research fellow ( n =1) and a plastic surgeon ( n =1)) to assess usability of digital image acquisition and storage for when the imaging process is conducted by the healthcare practitioners themselves, or by their patients. The study identifies the enablers and barriers of this emerging mode of medical practice. A thematic analysis was used to extract key themes from open-ended responses, which involved identifying themes and patterns within and across participants. Results Thirty-four healthcare practitioners (58%) had previously used a mobile dermatoscope within their practice. Participants most appreciated its use in their practice for lesion monitoring (59%) and record keeping (39%). Challenges reported were the increased time to support the additional workload (45%), technical issues (33%) and cost of equipment (27%). Practitioners were unsure (36%) or did not advocate teledermoscopy for direct-to-consumer use (41%). Only 23% supported the use of direct-to-consumer teledermoscopy. Conclusion While most practitioners are receptive to mobile teledermoscopy, there was less support for patient-initiated use, whereby the patient controls the imaging process. As technology improves rapidly it is important to evaluate practitioners’ acceptance and satisfaction of evolving telehealth services, moving forward with models of practice where healthcare practitioners and other healthcare providers will feel comfortable engaging in telehealth services.

show abstract

Section: Introductionmentioning

confidence: 99%

Evaluating healthcare practitioners’ views on store-and-forward teledermoscopy services for the diagnosis of skin cancer

et al. 2019

Self Cite

View full text Add to dashboard Cite

show abstract

“…Remotely enhancing SSE performance may require interactive apps that allow the patient to send images of concerning lesions to dermatologists or other HCPs and receive recommendations. At‐risk consumers appear to be ready to accept interactive apps 26 . When the quality of images of concerning lesions taken by users supports diagnostic interpretation, then, the app will engage users and extend health care access to at‐risk patients 27 …”

Section: Discussionmentioning

confidence: 99%

Remote skin self‐examination training of melanoma survivors and their skin check partners: A randomized trial and comparison with in‐person training

et al. 2020

View full text Add to dashboard Cite

show abstract

“…The Achieving Self-directed Integrated Cancer Aftercare (ASICA) Skin Checker app has been found to be feasible and acceptable for supporting SSE and triaging clinical review [30]. Studies on the preliminary assessment of diagnostic accuracy of patient-performed mobile teledermoscopy have demonstrated feasibility and acceptability for skin surveillance [31,32]. Our pilot randomised controlled trial in patients with early stage melanoma (n=100) demonstrated the feasibility of a patient-led surveillance intervention that incorporated both the ASICA app and patient-performed mobile teledermoscopy (manuscript in preparation) [33].…”

Section: Background and Rationale {6a}mentioning

confidence: 99%

Can Patient-Led Surveillance Detect Subsequent New Primary or Recurrent Melanomas and Reduce the Need for Routinely Scheduled Follow Up? A Protocol for the MEL-SELF Randomised Controlled Trial.

Ackermann

Smit

Janda

et al. 2021

Preprint

Self Cite

View full text Add to dashboard Cite

Background: Most subsequent new primary or recurrent melanomas might be self-detected if patients are trained to systematically self-examine their skin and have access to timely medical review (patient-led surveillance). Routinely scheduled clinic visits (clinician-led surveillance) is resource-intensive and has not been shown to improve health outcomes; fewer visits may be possible if patient-led surveillance is shown to be safe and effective. The MEL-SELF trial is a randomised controlled trial comparing patient-led surveillance with clinician-led surveillance in people who have been previously treated for localised melanoma. Methods: Stage 0/I/II melanoma patients (n=600) from dermatology, surgical, or general practice clinics in NSW Australia, will be randomised (1:1) to the intervention (patient-led surveillance, n=300) or control (usual care, n=300). Patients in the intervention will undergo a second randomisation 1:1 to polarised (n=150) or non-polarised (n=150) dermatoscope. Patient-led surveillance comprises an educational booklet, skin self-examination (SSE) instructional videos; 3-monthly email/SMS reminders to perform SSE; patient-performed dermoscopy with teledermatologist feedback; clinical review of positive teledermoscopy through fast-tracked unscheduled clinic visits; and routinely scheduled clinic visits following each clinician’s usual practice. Clinician-led surveillance comprises an educational booklet and routinely scheduled clinic visits following each clinician’s usual practice. The primary outcome, measured at 12-months, is the proportion of participants diagnosed with a subsequent new primary or recurrent melanoma diagnosed at an unscheduled clinic visit. Secondary outcomes include time from randomisation to diagnosis (of a subsequent new primary or recurrent melanoma and of a new keratinocyte cancer), clinicopathological characteristics of subsequent new primary or recurrent melanomas (including AJCC stage), psychological outcomes, and healthcare use. A nested qualitative study will include interviews with patients and clinicians, and a costing study we will compare costs from a societal perspective. We will compare the technical performance of two different models of dermatoscope (polarised vs non-polarised).Discussion: The findings from this study may inform guidance on evidence-based follow up care, that maximises early detection of subsequent new primary or recurrent melanoma and patient wellbeing, while minimising costs to patients, health systems, and society.Trial registration: Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12621000176864. Registered 18 February 2021, https://www.anzctr.org.au/ACTRN12621000176864.aspx

show abstract

Consumer Acceptance and Expectations of a Mobile Health Application to Photograph Skin Lesions for Early Detection of Melanoma

Cited by 39 publications

References 29 publications

Evaluating healthcare practitioners’ views on store-and-forward teledermoscopy services for the diagnosis of skin cancer

Evaluating healthcare practitioners’ views on store-and-forward teledermoscopy services for the diagnosis of skin cancer

Remote skin self‐examination training of melanoma survivors and their skin check partners: A randomized trial and comparison with in‐person training

Can Patient-Led Surveillance Detect Subsequent New Primary or Recurrent Melanomas and Reduce the Need for Routinely Scheduled Follow Up? A Protocol for the MEL-SELF Randomised Controlled Trial.

Contact Info

Product

Resources

About